Skip to main content
SpringerLink
Log in

Transplantation of Solid Organs, Tissues, and Prosthetic Devices in Patients with Antiphospholipid Antibodies

  • Chapter
Hughes Syndrome

  • 750 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Converse JM, Cassan P. The histological background of transplantation. In: Rapaport FT, Dausset J, eds. Human Transplantation. 1968:3–10.

    Google Scholar 

  2. Murray JE, Merrill JP. Renal homotransplantation in identical twins. Surgical Forum 1955;6:432.

    Google Scholar 

  3. Colman RW, Braun WE, Busch G, et al. Coagulation studies in the hyperacute and other forms of renal allograft rejection. N Eng J Med 1969;281:685–691.

    CAS  Google Scholar 

  4. Taylor LM, Chitwood RW, Dalman RL, et al. Antiphospolipid antibodies in vascular surgery patients. A cross-sectional study. Ann Surg 1994;220:544–551.

    PubMed  Google Scholar 

  5. Irish A. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention. Am J Cardiovasc Drugs 2004;4:139–149.

    PubMed  CAS  Google Scholar 

  6. Kujovich JL. Thrombophilia and thrombotic problems in renal transplant patients. Transplantation 2004;77:959–964.

    PubMed  Google Scholar 

  7. Wagenknecht DR, Sugi T, McIntyre JA. The evolution, evaluation and interpretation of antiphospholipid antibody assays. Clin Immunol Newsletter 1995;15:28–38.

    Google Scholar 

  8. McIntyre JA, Wagenknecht DR, Sugi T. Phospholipid binding plasma proteins required for antiphospholipid antibody detection — An overview. Am J Reprod Immunol 1997;37:101–110.

    PubMed  CAS  Google Scholar 

  9. McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies. Risk assessments for solid organ, bone marrow and tissue transplantation. Rheum Dis Clin North Am 2001;27:611–631.

    PubMed  CAS  Google Scholar 

  10. Liano F, Mampaso F, Martin FG, et al. Allograft membranous glomerulonephritis and renal-vein thrombosis in a patient with a lupus anticoagulant factor. Nephrol Dial Transplant 1988;3:684–689.

    PubMed  CAS  Google Scholar 

  11. Marcen R, Pascual J, Quereda C, et al. Lupus anticoagulant and thrombosis of kidney allograft vessels. Transplant Proc 1990;22:1396–1398.

    PubMed  CAS  Google Scholar 

  12. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992;65:79–82.

    PubMed  CAS  Google Scholar 

  13. Oymak O, Erdem Y, Yalcin AU, et al. Increased prevalence of anticardiolipin antibodies in renal transplant recipients. Nephron 1995;71:469–470.

    PubMed  CAS  Google Scholar 

  14. Fabrizi F, Sangiorgio R, Pontoriero G, et al. Antiphospholipid (aPL) antibodies in end-stage renal disease. J Nephrol 1999;12:89–94.

    PubMed  CAS  Google Scholar 

  15. Grandtnerova B, Gregova H, Mocikova H, et al. Anticardiolipin antibodies after kidney transplantation in patients with connective tissue disease. Transplant Proc 1999;31:228–229.

    PubMed  CAS  Google Scholar 

  16. Marcucci R, Zanazzi M, Bertoni E, et al. Risk factors for cardiovascular disease in renal transplant recipients: new insights. Transpl Int 2000;13(suppl 1):S419–S424.

    PubMed  Google Scholar 

  17. Ducloux D, Bourrinet E, Motte G, et al. Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients. Kidney Int 2003;64:1065–1070.

    PubMed  Google Scholar 

  18. Nampoory MR, Das KC, Johny KV, et al. Hypercoagualibility, a serious problem in patients with ESRD on maintenance dialysis, and its correction after kidney transplantation. Am J Kidney Dis 2003;42:797–805.

    PubMed  Google Scholar 

  19. Fischereder M, Gohring P, Schneeberger H, et al. Early loss of renal transplants in patients with thrombophilia. Transplantation 1996;65:936–939.

    Google Scholar 

  20. Wagenknecht DR, Becker DG, LeFor WM, et al. Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 1999;68:241–246.

    PubMed  CAS  Google Scholar 

  21. Murphy BG, Hill CM, Middleton D, et al. Increased renal allograft thrombosis in CAPD patients. Nephrol Dial Transplant 1994;9:1166–1169.

    PubMed  CAS  Google Scholar 

  22. Wagenknecht DR, Fastenau DR, Torry RJ, et al. Risk of early renal allograft failure is increased for patients with antiphospholipid antibodies. Transplant Int 2000;134:S78–S81.

    Google Scholar 

  23. Wagenknecht DR, Carter CB, McIntyre JA. Antiphospholipid antibodies are implicated in early renal allograft failure. Clin Hemost Rev 1998;12:19.

    Google Scholar 

  24. Wagenknecht DR, Fastenau DR, Torry RJ, et al. Antiphospholipid antibodies are a risk factor for early renal allograft failure: isolation of antiphospholipid antibodies from a thrombosed renal allograft. Transplant Proc 1999;31:285–288.

    PubMed  CAS  Google Scholar 

  25. Humar A, Key N, Ramcharan T, et al. Kidney retransplants after initial graft loss to vascular thrombosis. Clin Transplantation 2001;15:6–10.

    CAS  Google Scholar 

  26. Mondragon-Ramirez G, Bochicchio T, Garcia-Torres R, et al. Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS). Clin Transplant 1994;8:93–96.

    PubMed  CAS  Google Scholar 

  27. Chew CG, Bannister KM, Mathew TH, et al. Thrombotic microangiopathy related to anticardiolipin antibody in a renal allograft. Nephrol Dial Transplant 1999;14:436–438.

    PubMed  CAS  Google Scholar 

  28. Knight RJ, Schanzer H, Rand JH, et al. Renal allograft thrombosis associated with the antiphospholipid antibody syndrome. Transplantation 1995;60:614–615.

    PubMed  CAS  Google Scholar 

  29. Vaidya S, Wang CC, Gugliuzza C, et al. Relative risk of post-transplant renal thrombosis in patients with antiphospholipid antibodies. Clin Transplant 1998;12:439–444.

    PubMed  CAS  Google Scholar 

  30. Vaidya S, Sellers R, Kimball P, et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2000;69:1348–1352.

    PubMed  CAS  Google Scholar 

  31. Vaidya S, Gugliuzza K, Daller JA. Efficacy of anticoagulation threapy in end-stage renal disease patients with antiphospholipid antibody syndrome. Transplantation 2004;77:1046–1049.

    PubMed  CAS  Google Scholar 

  32. Morrissey PE, Ramirez PJ, Gohh RY, et al. Management of thrombophilia in renal transplant patients. Am J Transplant 2002;2:872–876.

    PubMed  Google Scholar 

  33. Friedman GS, Meier-Kriesche HU, Kaplan B, et al. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 2001;72:1073–1078.

    PubMed  CAS  Google Scholar 

  34. Ducloux D, Pellet E, Chalopin J-M. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplant Proc 1997;29:2400–2401.

    PubMed  CAS  Google Scholar 

  35. Ducloux D, Pellet E, Fournier V, et al. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. Transplantation 1999;67:90–93.

    PubMed  CAS  Google Scholar 

  36. Radhakrishnan J, Williams GS, Appel GB, et al. Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kid Dis 1994;23:286–289.

    PubMed  CAS  Google Scholar 

  37. Stone JH, Amend W, Criswell LA. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. Am J Kid Dis 1999;34:1040–1047.

    PubMed  CAS  Google Scholar 

  38. Mathis AS, Shah NK. Exaggerated response to heparin in a post-operative renal transplant recipient with lupus anticoagulant undergoing plasmapheresis. Transplantation 2004;77:957–958.

    PubMed  Google Scholar 

  39. Baid S, Pascual M, Williams WWJ, et al. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999;10:146–153.

    PubMed  CAS  Google Scholar 

  40. Wullstein C, Woeste G, Zapletal C, et al. Prothrombotic disorders in uremic type-1 diabetics undergoing simultaneous pancreas and kidney transplantation. Transplantation 2003;76:1691–1695.

    PubMed  CAS  Google Scholar 

  41. Wullstein C, Woeste G, Zapletal C, et al. Simultaneous pancreas-kidney transplantaion in patients with antiphospholipid syndrome. Transplantation 2003;75:562–563.

    PubMed  CAS  Google Scholar 

  42. Talenti DA, Falk GW, Carey WD, et al. Anticardiolipin antibody-associated cerebral infarction in cirrhosis: clearance of anticardiolipin antibody after liver transplantation. Am J Gastroenterol 1994;89:785–788.

    PubMed  CAS  Google Scholar 

  43. Yasutomi M, Egawa H, Kobayashi Y, et al. Living donor liver transplantation for Budd-Chiari syndrome with inferior vena cava obstruction and associated antiphospholipid antibody syndrome. J Pediatr Surg 2001;36:659–662.

    PubMed  CAS  Google Scholar 

  44. Villamil A, Sorkin E, Basta MC, et al. Catastrophic antiphospholipid syndrome complicating orthotopic liver transplantation. Lupus 2003;12:104–143.

    Google Scholar 

  45. Van Thiel DH, George M, Brems J, et al. Antiphospholipid antibodies before and after liver transplantation. Am J Gastroenterol 2003;98:460–465.

    PubMed  Google Scholar 

  46. Lallier M, St-Vil D, Dubois J, et al. Vascular complications after pediatric liver transplantation. J Ped Surg 1995;30:1122–1126.

    CAS  Google Scholar 

  47. Pascual M, Thadhani R, Laposata M, et al. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. Transplantation 1997;64:1361–1364.

    PubMed  CAS  Google Scholar 

  48. Vivarelli M, La Barba G, Legnani C, et al. Repeated graft loss caused by recurrent hepatic artery thrombosis after liver transplantation. Liver Transpl 2003;9:629–631.

    PubMed  Google Scholar 

  49. Collier JD, Sale J, Friend PJ, et al. Graft loss and the antiphospholipid syndrome following liver transplantation. J Hepatol 1998;29:999–1003.

    PubMed  CAS  Google Scholar 

  50. Pengo V, Biasiolo A, Marson P, et al. Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome. Clin Rheumatol 1996;15:504–507.

    PubMed  CAS  Google Scholar 

  51. McIntyre JA, Wagenknecht DR, Faulk WP. Antiphospholipid antibodies in heart transplant recipients. Clin Cardiol 1995;18:575–580.

    PubMed  CAS  Google Scholar 

  52. Lye WC, Henell KR, Norman DJ. Antiphospholipid antibodies causing positive flow crossmatches and interfering with T-cell immunophenotyping. Transplant Proc 1992;24:1683–1684.

    PubMed  CAS  Google Scholar 

  53. McIntyre JA, Higgins N, Britton R, et al. Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Transplantation 1996;62:691–623.

    PubMed  CAS  Google Scholar 

  54. Griffith BP, Kormos RL, Nastala CJ, et al. Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. Ann Thorac Surg 1996;61:396–398.

    PubMed  CAS  Google Scholar 

  55. Fastenau DR, Wagenknecht DR, McIntyre JA. Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients. Ann Thorac Surg 1999;68:137–142.

    PubMed  CAS  Google Scholar 

  56. Matsubayashi H, Fastenau D, McIntyre JA. Changes in platelet activation associated with left ventricular assist system placement. J Heart Lung Transplant 2000;19:462–468.

    PubMed  CAS  Google Scholar 

  57. Fastenau DR, Hormuth DA, McIntyre JA. Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin. Transplant Proc 1998;31:141–142.

    Google Scholar 

  58. Fastenau DR, McIntyre JA. Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant. Ann Thorarc Surg 2000;69:1867–1872.

    CAS  Google Scholar 

  59. Unger P, Plein D, Pradier O, et al. Thrombosis of aortic valve homograft associated with lupus anticoagulant antibodies. Ann Thorac Surg 2004;77:312–314.

    PubMed  Google Scholar 

  60. Matsuyama K, Ueda Y, Ogino H, et al. Aortic valve replacement for aortic regurgitation in a patient with primary antiphoshpolipid syndrome. Jpn Circ J 1999;63:725–726.

    PubMed  CAS  Google Scholar 

  61. Dornan RIP. Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br J Anaesth 2004;92:748–754.

    PubMed  CAS  Google Scholar 

  62. Brownstein L, Bartholomew TP, Silver DG, et al. A case report of mitral valve replacement in a patient with lupus antibody syndrome. Perfusion 2003;18:373–376.

    PubMed  Google Scholar 

  63. Kato Y, Isobe F, Sasaki Y, et al. Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardvasc Surg 2001;49:728–731.

    CAS  Google Scholar 

  64. Da Silva AN, Ferreira LD, Monaco CG, et al. Intracardiac thrombosis and mitral prosthesis dysfunction in systemic lupus erythematosus. A case report. Rev Port Cardiol 2003;22:213–219.

    PubMed  Google Scholar 

  65. Berkun Y, Elami A, Meir K, et al. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2004;127:414–420.

    PubMed  Google Scholar 

  66. Simonneau G, Azarian R, Brenot F, et al. Surgical management of unresolved pulmonary embolism. A personal series of 72 patients. Chest 1995;107:52S–55S.

    PubMed  CAS  Google Scholar 

  67. Asherson RA, Higenbottam TW, Xuan Dinh AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990;17:1292–1298.

    PubMed  CAS  Google Scholar 

  68. Yeatman M, McNeil K, Smith JA, et al. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant 1995;15:144–149.

    Google Scholar 

  69. Nathan SD, Barnett SD, Urban BA, et al. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients. Chest 2003;123:1758–1763.

    PubMed  Google Scholar 

  70. Magro CM, Allen J, Pope-Harman A, et al. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol 2003;119:556–567.

    PubMed  Google Scholar 

  71. Nathan SD, Barnett SD. Reply to letter to the editor: Idiopathic pulmonary fibrosis in transplantation. Chest 2003;124:2404.

    Google Scholar 

  72. Jankowich MD. Idiopathic pulmonary fibrosis in transplantation. Chest 2003;124:2404.

    PubMed  Google Scholar 

  73. Dauerman HL, Cutlip DE, Selke FW. Intracoronary thrombolysis in the treatment of graft closure immediately after CABG. Ann Thorac Surg 1996;62:280–283.

    PubMed  CAS  Google Scholar 

  74. Nakayama M, Kumon K, Yagagi N, et al. Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass. Jpn J Surg 1998;28:423–426.

    CAS  Google Scholar 

  75. Lee RW, Taylor LM, Landry GJ, et al. Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies. J Vascular Surg 1996;24:524–531.

    CAS  Google Scholar 

  76. Nielsen TG, Nordestgaard BG, von Jessen F, et al. Antibodies to cardiolipin may increase the risk of failure of peripheral vein bypasses. Eur J Endovasc Surg 1997;14:177–184.

    CAS  Google Scholar 

  77. Gargiulo P, Goldberg J, Romani B, et al. Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus. Clin Exp Immunol 1999;118:30–34.

    PubMed  CAS  Google Scholar 

  78. Ray SA, Rowley MR, Loh A, et al. Hypercoagulable states in patients with leg ischaemia. Br J Surg 1994;81:811–814.

    PubMed  CAS  Google Scholar 

  79. Prakash R, Miller CC, Suki WN. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 1995;26:347–352.

    PubMed  CAS  Google Scholar 

  80. LeSar CJ, Merrick HW, Smith MR. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 1999;189:73–81.

    PubMed  CAS  Google Scholar 

  81. Conlan MG, Haire WD, Kessinger A, et al. Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation. Bone Marrow Transplant 1991;7:475–479.

    PubMed  CAS  Google Scholar 

  82. Greeno EW, Haake R, McGlave P, et al. Lupus inhibitors following bone marrow transplant. Bone Marrow Transplant 1995;15:287–291.

    PubMed  CAS  Google Scholar 

  83. Qasim W, Gerritsen B, Veys P. Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 1998;21:845–847.

    PubMed  CAS  Google Scholar 

  84. Ollalla JI, Ortin M, Hermida G, et al. Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;23:83–85.

    Google Scholar 

  85. Musso M, Porretto F, Crescimanno A, et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans Syndrome. Lupus 1998;7:492–494.

    PubMed  CAS  Google Scholar 

  86. Hashimoto N, Iwasaki T, Sekiguchi I, et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant 2004;33:863–866.

    PubMed  CAS  Google Scholar 

  87. Elhasid R, Rowe JM, Berkowitz D, et al. Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004;33:1257–1259.

    PubMed  CAS  Google Scholar 

  88. Mizutani H, Engelman RW, Kinjoh K, et al. Prevention and induction of occlusive coronary vascular disease in autoimmune (W/B)F1 mice by haploidentical bone marrow transplantation: Possible role for anticardiolipin autoantibodies. Blood 1993;82:3091–3092.

    PubMed  CAS  Google Scholar 

  89. Mengarelli A, Minotti C, Palumbo G, et al. High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. Br J Haematol 2000;108:126–131.

    PubMed  CAS  Google Scholar 

  90. Gharavi AE, Pierangeli S, Harris EN. New developments in viral peptides and APL induction. J Autoimmun 2000;15:227–230.

    PubMed  CAS  Google Scholar 

  91. Morio S, Oh H, Hirasawa A, et al. Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;8:147–149.

    PubMed  CAS  Google Scholar 

  92. Fastenau D, Haire W, Schneider J, et al. The pre-conditioning incidence of antiphospholipid antibodies is not significantly increased in patients with bone marrow transplant-related organ dysfunction. Bone Marrow Transplant 1998;22:681–684.

    PubMed  CAS  Google Scholar 

  93. Sohngen D, Heyll A, Meckenstock G, et al. Antiphospholipid syndrome complicating chronic graft-verses-host disease after allogenic bone marrow transplantation. Am J Hematol 1994;47:143–144.

    PubMed  CAS  Google Scholar 

  94. Quaranta S, Shulman H, Ahmed A, et al. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol 1999;91:106–116.

    PubMed  CAS  Google Scholar 

  95. Kharfan-Dabaja MA, Morgensztern D, Santos E, et al. Acute graft-versus-host disease (aGVHD) presenting with an acquired lupus anticoagulant. Bone Marrow Transplant 2003;31:129–131.

    PubMed  CAS  Google Scholar 

  96. Mevorach D. The immune response to apoptotic cells. Ann N Y Acad Sci 1999;887:191–198.

    PubMed  CAS  Google Scholar 

  97. Mevorach D, Zhou JL, Song X, et al. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998;188:387–392.

    PubMed  CAS  Google Scholar 

  98. Manfredi AA, Rovere P, Galati G, et al. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum 1998;41:205–241.

    PubMed  CAS  Google Scholar 

  99. Mizutani H, Engelman RW, Kinjoh K, et al. Gastrointestinal vasculitis in autoimmune-prone (NZW X BXSB)F1 mice: association with anticardiolipin autoantibodies. Proc Soc Exp Biol Med 1995;209:279–285.

    PubMed  CAS  Google Scholar 

  100. Adachi Y, Inaba M, Amoh Y, et al. Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology 1995;192:218–230.

    PubMed  CAS  Google Scholar 

  101. Blank M, Krause I, Lanir N, et al. Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. Arthritis Rheum 1995;38:115–162.

    PubMed  CAS  Google Scholar 

  102. Kazory A, Ducloux D. Acquired hypercoagulable state in renal transplant recipients. Thromb Haemost 2004;91:646–654.

    PubMed  CAS  Google Scholar 

  103. Joseph RE, Radhakrishnan J, Appel GB. Antiphospholipid antibody syndrome and renal disease. Curr Opin Nephrol Hypertens 2001;10:175–181.

    PubMed  CAS  Google Scholar 

  104. McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies and renal transplantation: a risk assessment. Lupus 2003;12:555–559.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. HLA-Vascular Biology Laboratory, St. Francis Hospital and Health Center, Indianapolis, IN, USA

    Dawn R. Wagenknecht BS, MS, CHS (ABHI) & John A. McIntyre phD, FRCPath, Dip ABHI

  2. Department of Biology, Indiana University-Purdue University at Indianapolis, Indianapolis, IN, USA

    John A. McIntyre phD, FRCPath, Dip ABHI

Authors
  1. Dawn R. Wagenknecht BS, MS, CHS (ABHI)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John A. McIntyre phD, FRCPath, Dip ABHI
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Wagenknecht, D.R., McIntyre, J.A. (2006). Transplantation of Solid Organs, Tissues, and Prosthetic Devices in Patients with Antiphospholipid Antibodies. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_19

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_19

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation